SPI1 and cancer: Glycolytic capacity and metabolite measurement assays indicated that conditional medium of TANs significantly facilitated glycolytic process of cancer cells (Figures 3D and S4D, E), while silencing of SPI1 suppressed these effects in cancer cells (Figures 3D and S4D, E).